__timestamp | Honeywell International Inc. | PACCAR Inc |
---|---|---|
Wednesday, January 1, 2014 | 2926000000 | 215600000 |
Thursday, January 1, 2015 | 2854000000 | 239800000 |
Friday, January 1, 2016 | 2143000000 | 247200000 |
Sunday, January 1, 2017 | 1835000000 | 264700000 |
Monday, January 1, 2018 | 1809000000 | 306100000 |
Tuesday, January 1, 2019 | 1556000000 | 326600000 |
Wednesday, January 1, 2020 | 1334000000 | 273900000 |
Friday, January 1, 2021 | 1333000000 | 324100000 |
Saturday, January 1, 2022 | 1478000000 | 341200000 |
Sunday, January 1, 2023 | 1456000000 | 410900000 |
Monday, January 1, 2024 | 1536000000 | 452900000 |
Cracking the code
In the ever-evolving landscape of technology and innovation, research and development (R&D) spending is a critical indicator of a company's commitment to future growth. Over the past decade, Honeywell International Inc. and PACCAR Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Honeywell consistently allocated a significant portion of its resources to R&D, peaking in 2014 with expenditures nearly 13 times higher than PACCAR's. However, a noticeable decline in Honeywell's R&D spending is evident, dropping by over 50% from 2014 to 2023. In contrast, PACCAR has shown a steady increase, with a 90% rise in R&D spending over the same period.
This trend highlights a strategic shift, with PACCAR closing the gap in innovation investment, potentially positioning itself as a formidable competitor in the industry.
Research and Development Investment: Honeywell International Inc. vs 3M Company
Revenue Showdown: Honeywell International Inc. vs PACCAR Inc
R&D Insights: How Honeywell International Inc. and Northrop Grumman Corporation Allocate Funds
R&D Insights: How Honeywell International Inc. and Cummins Inc. Allocate Funds
Honeywell International Inc. and PACCAR Inc: A Detailed Examination of EBITDA Performance
R&D Insights: How Honeywell International Inc. and Axon Enterprise, Inc. Allocate Funds